Home Business Capital Neimeth Announces Conclusion Of 2.37 Billion Rights Issue
Capital

Neimeth Announces Conclusion Of 2.37 Billion Rights Issue

Share
Share

Neimeth International Pharmaceuticals Plc (the Company) wishes to inform that following close of its Rights Issue exercise on September 15, 2022 that it has received a No-Objection from the Securities and Exchange Commission (SEC) on the allotment of 2,373,947,500 Ordinary Shares at 81.55 per share on the basis of 5 new Ordinary Shares for every 4 Ordinary Shares held as at the close of business on Friday, April 22, 2022. The Rights Issue was fully subscribed, leading to fresh injection of 3.68 billion which will further position the company for growth, improve its capital structure, deleverage its balance sheet, and fund its working capital needs.

The shares allotted will be credited to the CSCS account of allottees by the Registrars to the Issue, in line with the basis of allotment of the shares as approved by the SEC. Allotment of the shares will bring about a change in the Shareholding Structure of the Company. The new Shareholding Structure will be communicated as appropriate once updated.

Share

Businesstoday Magazine

Businesstoday Conference/Awards

Related Articles

Stanbic IBTC Asset Management Launches Anti-Scam Campaign To Protect Mutual Fund Holders

Stanbic IBTC Asset Management has implemented strong measures to safeguard its customers...

MTN Nigeria Raises N75.18Bn Via Commercial Paper Issuance

MTN Nigeria Communications Plc has announced the successful completion of its Series...

Stanbic IBTC Clinches Multiple Awards At The 2024 FMDQ Gold Awards

Stanbic IBTC Clinches Multiple Awards At The 2024 FMDQ Gold Awards  ...

Access Holdings Reports 82.8% Growth In Q3 PAT To ₦457.7 billion

*As Total Assets Hit To ₦41.1 Trillion   Access Holdings Plc, one...